The generic name of Novolin 50R is Arginine Biosynthetic Human Insulin Injection, and the exact dosage varies from person to person, and is used for the treatment of diabetes mellitus, which is generally between 0.3 and 1.0 international units per kilogram of body weight.
The indications for Arginine Biosynthetic Human Insulin Injection are for diabetic patients, and the dosage of the drug needs to be individualized according to the patient’s condition, and the general amount needed is between 0.3 and 1.0 international units per kilogram of body weight per day. If the patient has insulin resistance, the amount of insulin needed may increase.
It should be noted that some patients may experience adverse reactions such as rubella, rash, peripheral neuropathy during the use of Arginine Biosynthetic Human Insulin Injection, and it is contraindicated for those who are allergic to the active ingredient or other ingredients in this product.
For diabetic patients, Arginine Biosynthetic Human Insulin Injection should be used under the guidance of a doctor, avoid reducing or increasing the dosage on their own.